![](/img/cover-not-exists.png)
P505 Different failure rates after non-medical switching of 744 patients from adalimumab originator to 2 different adalimumab biosimilars at Cambridge University Hospitals, UK: real-world experience
Rosembert, D, Malaviya, A, How, J, Tomlison, J, Toh, F, Roe, M, Nightingale, A, Garcia-Sueiro, C, Herbert, P, Jadon, D, Norris, P, Thomas, J, Magsino, J, Negoescu, A, Raine, TVolume:
14
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjz203.634
Date:
January, 2020
File:
PDF, 244 KB
2020